Search Results - "Hackinger S"

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

Authors: van Dorp J Pipinikas C Suelmann BBM et al.

Source: Nature medicine [Nat Med] 2024 Jan; Vol. 30 (1), pp. 304.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE

Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer.

Authors: Huang, Dingzhi Lin, Gen Chu, Qian et al.

Source: Thoracic Cancer. Dec2023, Vol. 14 Issue 34, p3421-3429. 9p.

Enrichment of mutated DNA enables ultra-sensitive ctDNA detection in NSCLC using shallow targeted sequencing.

Authors: Labrousse P Russell H Stetson D et al.

Source: Scientific reports [Sci Rep] 2026 Jun 13. Date of Electronic Publication: 2026 Jun 13.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Is Radiographic Aftercare Obsolete? How Testing Positive for ctDNA Can Be a Precedent for Late Relapse, Even in Low-Risk Hormone-Receptor-Positive Breast Cancer.

Authors: Pfister, Kerstin Huesmann, Sophia Fink, Angelina et al.

Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 17, p8498. 8p.

The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC).

Authors: Gillis, Roni Zahavi, Tamar Peled, Nir et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1246. 15p.

Salivary cell-free DNA in head and neck cancer: emerging clinical applications and future perspectives.

Authors: Patel, Vaishnavi N. Patel, Aditi B. Lotia, Shreya A. et al.

Source: Oncology Reviews. 2026, p1-10. 10p.

Targeting Osteoporosis-Osteoarthritis Comorbidity: Multi-Omics Identification of SON and Exploration of Therapeutic Agents.

Authors: Jiang, Kunlong Du, Jun Yang, Peng et al.

Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 11, p4905. 20p.

Sensitive monitoring of xenograft cancer models using cell-free DNA.

Authors: An, Yunyun Lin, Huizhen Tang, Bianbian et al.

Source: Journal of Translational Medicine. 6/17/2025, Vol. 23 Issue 1, p1-3. 3p.

Recurrence prediction using circulating tumor DNA in patients with early-stage non-small cell lung cancer after treatment with curative intent: A retrospective validation study.

Authors: Schuurbiers, Milou M. F. Smith, Christopher G. Hartemink, Koen J. et al.

Source: PLoS Medicine. 4/15/2025, Vol. 22 Issue 4, p1-23. 23p.

Genetic markers for knee osteoarthritis presence are not associated with disease progression - data from the IMI-APPROACH cohort.

Authors: Bentvelzen, Mieke L. M. Welsing, Paco M.J. Moingeon, Philippe et al.

Source: PLoS ONE. 6/24/2025, Vol. 20 Issue 6, p1-13. 13p.

HPV Detection in Oropharyngeal Cancer: A Narrative Review of Diagnostic and Emerging Molecular Approaches †.

Authors: López, Fernando Bree, Remco de Sreeram, M. P. et al.

Source: Diagnostics (2075-4418). Apr2026, Vol. 16 Issue 7, p1010. 25p.

Drug-Tolerant Persister Cells and Tumor Dormancy in NSCLC: A New Frontier in Overcoming Therapeutic Resistance.

Authors: Lalla, Mumtu Ratnani, Akshay Yang, Jihua et al.

Source: Cancers. Mar2026, Vol. 18 Issue 5, p779. 14p.

The role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer: biomarker analyses from a prospective phase II trial.

Authors: Liu, Bing Tao, Ye Zhuo, Minglei et al.

Source: BMC Medicine. 11/5/2025, Vol. 23 Issue 1, p1-17. 17p.

Knee Health Is a Major Determinant of Mobility Across the Healthspan.

Authors: Peoples, Brandon Marshall Harrison, Kenneth D. Samaan, Michael A. et al.

Source: Journal of Functional Morphology & Kinesiology. Dec2025, Vol. 10 Issue 4, p454.

KRAS Mutations in Circulating Tumor DNA for Lung Cancer Diagnosis: A Comprehensive Meta-Analysis.

Authors: Buszka, Karolina Gąsiorowski, Łukasz Dompe, Claudia et al.

Source: Cancers. Jan2026, Vol. 18 Issue 2, p250. 12p.

Artificial Intelligence-Enhanced Liquid Biopsy and Radiomics in Early-Stage Lung Cancer Detection: A Precision Oncology Paradigm.

Authors: Cherukuri, Swathi Priya Kaur, Anmolpreet Goyal, Bipasha et al.

Source: Cancers. Oct2025, Vol. 17 Issue 19, p3165. 31p.

Simplifying Knee OA Prognosis: A Deep Learning Approach Using Radiographs and Minimal Clinical Inputs.

Authors: Wang, Cheng-Tzu Chang, Kai-Ting Lai, Feipei et al.

Source: Diagnostics (2075-4418). Oct2025, Vol. 15 Issue 19, p2543. 10p.

Multi-trait association studies discover pleiotropic loci between Alzheimer's disease and cardiometabolic traits.

Authors: Bone, William P. Siewert, Katherine M. Jha, Anupama et al.

Source: Alzheimer's Research & Therapy. 2/4/2021, Vol. 13 Issue 1, p1-14. 14p.

Advanced Minimal Residual Disease Detection Using a Novel Circulating Tumor DNA Assay: A Report of Two Cases.

Authors: Azzi, Georges Slavin, Thomas P. Izaguirre-Carbonell, Jesus et al.

Source: Case Reports in Oncology. 2025, Vol. 18 Issue 1, p1113-1118. 6p.

Analytical validation of a novel comprehensive genomic profiling informed circulating tumor DNA monitoring assay for solid tumors.

Authors: Zollinger, Daniel R. Rivers, Elizabeth Fine, Alexander et al.

Source: PLoS ONE. 5/16/2024, Vol. 19 Issue 5, p1-18. 18p.